Practical guidelines on the use of insulin lispro in elderly diabetic patients

Drugs and Aging

Volumn 12, Issue 2, 1998, Pages 103-113

  Benbarka, Mahmoud M ^a   Prescott, Pamela T ^a   Aoki, Thomas T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

AGED; DIET; DRUG STORAGE; EXERCISE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PRACTICE GUIDELINES;

EID: 0031942792     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199812020-00003     Document Type: Review

References (58)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97
2. National Institute of Diabetes and Digestive and Kidney Disease. Diabetes statistics (NIH Publication 94-3822). Bethesda (MD): US Department of Health and Human Services, 1994 Sep
3. American Diabetes Association. Diabetes 1993 vital statistics. Alexandria (VA): American Diabetes Association, 1993: 1-59
4. DeFronzo RA. Glucose intolerance in aging: evidence for tissue insensitivity to insulin. Diabetes 1979; 28: 1095-101
5. Rowe JW, Minaker KL, Pallotta JA. Characterization of insulin resistance of aging. J Clin Invest 1983; 71: 1581-7
6. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US populations, ages 20-74 years. Diabetes 1990; 3: 523-34
7. Harris MI. Epidemiology of diabetes mellitus among the elderly. Clin Geriatr Med 1990; 6: 703-19
8. Kilvert A, Fitzgerald MG, Wright AD, et al. Clinical characteristics and aetiological classification of insulin-dependent diabetes in the elderly. Q J Med 1986; 60: 865-72
9. Gambert SR. Atypical presentation of diabetes mellitus in the elderly. Clin Geriatr Med 1990; 6: 721-9
10. DeFronzo RA, Ferrannini E, Koivisto V, New concepts in the pathogenesis and treatment of non-insulin dependent diabetes mellitus. Am J Med 1983; 74: 52-81
11. Lefebvre PJ, Paolisso G, Sheen AT, et al. Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications. Diabetologia 1987; 30: 443-52
12. Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 1231-9
13. Lang DA, Matthews DR, Burnett M, et al. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 1981; 30: 435-9
14. DeFronzo RA. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988; 37: 667-87
15. Jackson RA, Hawa MF, Roshania RD, et al. Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes 1988; 37: 119-29
16. Chen M, Bergman RN, Pacini G, et al. Pathogenesis of age-reluted glucose in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab 1985; 60: 13-20
17. Elahi D, Muller D, Tzankoff S, et al. Effects of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man. J Gerontol 1982; 37: 385-91
18. Meneilly GS, Minaker KL, Elahi D, et al. Insulin action in aging man: evidence for tissue-specific differences at low physiologic insulin levels. J Gerontol 1987; 42: 196-201
19. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1977; 19: 653-63
20. Lesser GT, Deutsch S, Markofsky J. Use of independent measurements of body fat to evaluate overweight and underweight. Metabolism 1971; 20: 792-804
21. Andres R, Elahi D, Tobin JD, et al. Impact of age on weight goals. Ann Intern Med 1985; 103: 1030-3
22. Elahi D, Anderson DK, Muller DC, et al. The extrinsic enhancement of glucose stimulated insulin release: the role of GIP in aging, obesity, and non-insulin dependent diabetes mellitus. Diabetes 1984: 33: 950-7
23. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985; 121: 91-106
24. The Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
25. Ohkubo Y, Hishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28103-17
26. Klein R. Hyperglycemia and miorovasculur and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-68
27. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care 1997; 20 Suppl. 1: S5-13
28. Skarfors ET, Wegener TA, Lithell H, et al. Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men: a feasibility study over 2 years. Diabetologia 1987; 30: 930-3
29. Harris MI. Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the US population. Diabetes Care 1991; 14: 639-48
30. Galloway JA. Treatment of NIDDM with insulin agonists or substitutes. Diabetes Care 1990; 13: 1209-39
31. Sautiago J, editor. Medical management of insulin-dependent (type I) diabetes. 2nd ed. New York: American Diabetes Association, 1994: 35-7
32. Skyler JS. Insulin pharmacology. Med Clin North Am 1988; 72: 133-54
33. Skyler J. Human insulin: a decade of experience and future developments. Diabetes Care 1993; 16: 1-65
34. Seigler DE, Olsson GM, Skyler J. Morning versus bedtime isophane insulin regimens in patents with non-insulin-dependent diabetes mellitus. Diabetic Med 1992; 8: 826-33
35. Torlone E, Fanelli C, Rambotti AM, et al. Pharmacokinetics, pharmacodynamics and glucose counter regulation following subcutaneous injection of the monomeric insulin analogue [Lys (B28), Pro (B29)] in IDDM. Diabetologia 1994; 37: 713-20
36. Holleman F, Van den Brand JJG, Hoven RARA, et al. Comparison of Lys B28, Pro B29-human insulin analogs and regular human insulin in the correction of incidental hyperglycemia. Diabetes Care 1996; 19: 1426-9
37. Howey DC, Bowsher RR, Brunelle RL, et al. Lys (B28), Pro (B29)-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396-402
38. Galloway JA, Chance RE. Improving insulin therapy: achievements and challenges. Horm Metab Res 1994; 26: 591-8
39. Antsiferov M, Woodwarth JR, Mayorov A, et al. Lower within patient variability in postprandial glucose excursion with lispro insulin analog compared with regular insulin [abstract]. Diabetes 1995; 44: 214A
40. Zinman B, Chiasson JL, Tildesley H, et al. Insulin lispro in CSII: results of a double-blind, crossover study [abstract]. Diabetes 1996; 45: 28A
41. 'Humalog' [insulin lispro injection (DNA origin)]. Package insert. Indianapolis: Eli Lilly & Co., 1996
42. Pampanelli S, Torlone E, Lalli C, et al. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic β-cell function. Diabetes Care 1995; 18: 1452-9
43. Walter RM. Hypoglycemia: still a risk in the elderly. Geriatrics 1990; 45: 69-75
44. Bruttomesso D, Pianta A, Valerio A, et al. Fast acting insulin lispro improves glucose tolerance of NIDDM by inhibiting hepatic glucose production. Diabetes 1996; 45: 140A
45. Crowley M, Alexander W, Cessar DJ, et al. Insulin lispro improves postprandial BG control in type 1 and type 2 diabetes without increasing the frequency of hypoglycemia [abstract]. Diabetic Med 1995; 12 Suppl. 2: S33
46. Anderson JH, Brunelle RL, Keohane P, et al. Meal time treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patient with non-insulin dependent diabetes mellitus. Arch Intern Med 1997; 157: 1249-55
47. Howey DC, Bowsher RR, Brunelle RL, et al. Lispro human insulin: effect of injection time on postprandial glycemia. Clin Pharmacol Ther 1995; 58: 459-69
48. Sindaco P, Ciofetta M, Lalli C, et al. Importance of basal insulin in intensive treatment of IDDM with lispro insulin [abstract]. Diabetes 1997; 46 Suppl. 1: 331A
49. Jansson PA, Ebeling P, Smith U. Glycemic control in IDDM is improved by optimized combination of insulin lispro and basal insulin [abstract]. Diabetes 1997; 46 Suppl. 1: 162A
50. Feinglos MN, Lane JD, Thacker CH, et al. Pre-prandial insulin lispro improves glucose control in patients with secondary sulfonylurea failure [abstract]. Diabetes 1996; 45: 286A
51. Schernthaner G, Wein W, Sandholzer K, et al. Postprandial insulin lispro - a new option in type I diabetic patients [abstract]. Diabetes 1997; 46 Suppl. 1: 98A
52. Strachani M, Frieri B. Efficacy of insulin lispro administered before or after food: influence of meal composition [abstract]. Diabetes 1997; 46 Suppl. 1: 150A
53. Brock DB, Brody JA. Statistical and epidemiological characteristics. In: Andres R. Bierman EL, Hazzard WR, editors. Principles of geriatric medicine. New York: McGraw-Hill, 1985: 53-71
54. Tonino RP. Diabetes education: what should health care providers in long term nursing care facilities know about diabetes? Diabetes Care 1990; 13 Suppl. 2: 55-9
55. National Center for Health Statistics. The National Nursing Home Survey 1985 (Stock #017-022-010-658). Hyattsville (MD): National Center for Health Statistics, 1985
56. Genuth S. Insulin in non-insulin-dependent patients. In: Mazzaferri EL, Bar RS, Kreisberg RA, editors. Advances in endocrinology and metabolism. Vol. 3. St Louis (MO): Mosby Year-Book, 1992: P84-93
57. Mazze RS, Etzwiler DD, Strock E, et al. Staged diabetes management: toward an integrated model of diabetes care. Diabetes Care 1994; 17: 56-66
58. Genuth S. Insulin use in NIDDM. Diabetes Care 1990; 13: 1240-64